Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis.

[1]  M. Mandelboim,et al.  Treatment of adenoviral keratoconjunctivitis with a combination of povidone‐iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study , 2017, Acta ophthalmologica.

[2]  A. Huang,et al.  Herpes simplex keratitis: challenges in diagnosis and clinical management , 2017, Clinical ophthalmology.

[3]  R. Y. Abe,et al.  Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial , 2015, Current eye research.

[4]  W. Rutala,et al.  Selection of the Ideal Disinfectant , 2014, Infection Control & Hospital Epidemiology.

[5]  J. Vander,et al.  Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics. , 2013, American journal of ophthalmology.

[6]  A. Azari,et al.  Conjunctivitis: a systematic review of diagnosis and treatment. , 2013, JAMA.

[7]  G. Micali,et al.  Antiseptics in the era of bacterial resistance: A focus on povidone iodine , 2013 .

[8]  Vivian T. Yin,et al.  Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection. , 2013, JAMA ophthalmology.

[9]  J. Vander,et al.  Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection. , 2012, Ophthalmology.

[10]  Darlene Miller,et al.  In vitro efficacy of a povidone–iodine 0.4% and dexamethasone 0.1% suspension against ocular pathogens , 2011, Journal of cataract and refractive surgery.

[11]  C. Bunce,et al.  A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis , 2011, British Journal of Ophthalmology.

[12]  T. Foster,et al.  Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis. , 2011, Investigative ophthalmology & visual science.

[13]  C. Hutnik,et al.  Evidence-based treatment of acute infective conjunctivitis: Breaking the cycle of antibiotic prescribing. , 2009, Canadian family physician Medecin de famille canadien.

[14]  W. Trattler,et al.  A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis , 2009, Advances in therapy.

[15]  G. Dutton,et al.  Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance , 2009, British Journal of Ophthalmology.

[16]  J. Schneider,et al.  Cost Effectiveness of a Point-of-Care Test for Adenoviral Conjunctivitis , 2008, The American journal of the medical sciences.

[17]  S. Rauchman,et al.  A patient preference comparison of Azarga™ (brinzolamide/timolol fixed combination) vs Cosopt® (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension , 2008, Clinical ophthalmology.

[18]  E. Stefánsson,et al.  Comparison of topical 0.7% dexamethasone–cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[19]  G. ter Riet,et al.  Diagnostic impact of signs and symptoms in acute infectious conjunctivitis: systematic literature search , 2003, BMJ : British Medical Journal.

[20]  J. V. van Meurs,et al.  Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate. , 2002, Ophthalmology.

[21]  R. Tandon,et al.  Topical ciprofloxacin‐dexamethasone combination therapy after cataract surgery: randomized controlled clinical trial , 2001, Journal of cataract and refractive surgery.

[22]  S. Isenberg,et al.  Efficacy of topical povidone-iodine during the first week after ophthalmic surgery. , 1997, American journal of ophthalmology.

[23]  M. Arita,et al.  Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. , 1997, Dermatology.

[24]  E. Romanowski,et al.  The effects of corticosteroids of adenoviral replication. , 1996, Archives of ophthalmology.

[25]  E. Romanowski,et al.  Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. , 1993, Ophthalmology.

[26]  J. Menikoff,et al.  Prophylaxis of endophthalmitis with topical povidone-iodine. , 1991, Ophthalmology.

[27]  J. Pepose,et al.  The sensitivity of Neisseria gonorrhoeae, Chlamydia trachomatis, and herpes simplex type II to disinfection with povidone-iodine. , 1990, American journal of ophthalmology.

[28]  K. Nelson,et al.  Epidemiology of epidemic keratoconjunctivitis. , 1987, Epidemiologic reviews.

[29]  R. Berkelman,et al.  Increased bactericidal activity of dilute preparations of povidone-iodine solutions , 1982, Journal of clinical microbiology.